Brief: Nyrada Says NYX-PCSK9I With Statin Achieves 65% Cholesterol Reduction In Preclinical Study
29/06/2021 24:34
June 29 (Reuters) - Nyrada Inc NYR.AX :
* NYRADA'S NYX-PCSK9I WITH STATIN ACHIEVES 65% CHOLESTEROL
REDUCTION IN PRECLINICAL STUDY
Source text for Eikon: ID:nASX25qbvL
Further company coverage: NYR.AX
((Reuters.Briefs@thomsonreuters.com;))